Here, we review the relationship between Aβ accumulation, the insulin signaling pathway, tau hyperphosphorylation, and microglia activation (Figure 1), and we summarize different strategies for AD treatment, particularly the intermediary role of insulin signaling in AD pathology. The gene discussed is MAPT; the disease is Alzheimer disease.